Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.222NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.470NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.31 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.51 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.122.5 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.40.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.196NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.459NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.117NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.381NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.237NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.382NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.60NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.9.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KT.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.9.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.69NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.98NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.71NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HT.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.90NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.18.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used